Abstract
Summary Primitive neuroectodermal tumors of the central nervous system (CNS-PNETs) are highly aggressive, poorly differentiated embryonal tumors occurring predominantly in young children but also affecting adolescents and adults. Herein, we demonstrate that a significant proportion of institutionally diagnosed CNS-PNETs display molecular profiles indistinguishable from those of various other well-defined CNS tumor entities, facilitating diagnosis and appropriate therapy for patients with these tumors. From the remaining fraction of CNS-PNETs, we identify four new CNS tumor entities, each associated with a recurrent genetic alteration and distinct histopathological and clinical features. These new molecular entities, designated "CNS neuroblastoma with FOXR2 activation (CNS NB-FOXR2)," "CNS Ewing sarcoma family tumor with CIC alteration (CNS EFT-CIC)," "CNS high-grade neuroepithelial tumor with MN1 alteration (CNS HGNET-MN1)," and "CNS high-grade neuroepithelial tumor with BCOR alteration (CNS HGNET-BCOR)," will enable meaningful clinical trials and the development of therapeutic strategies for patients affected by poorly differentiated CNS tumors.
Original language | English |
---|---|
Journal | Cell |
Volume | 164 |
Issue number | 5 |
Pages (from-to) | 1060-72 |
Number of pages | 13 |
ISSN | 0092-8674 |
DOIs | |
Publication status | Published - 25 Feb 2016 |
Keywords
- Amino Acid Sequence
- Central Nervous System Neoplasms
- Child
- DNA Methylation
- Forkhead Transcription Factors
- Gene Expression Profiling
- Gene Expression Regulation, Neoplastic
- Humans
- Molecular Sequence Data
- Neuroectodermal Tumors
- Proto-Oncogene Proteins
- Repressor Proteins
- Signal Transduction
- Tumor Suppressor Proteins
- Journal Article
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't